Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

933
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
933
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Half-life of a Reaction02:42

Half-life of a Reaction

39.5K
The half-life of a reaction (t1/2) is the time required for one-half of a given amount of reactant to be consumed. In each succeeding half-life, half of the remaining concentration of the reactant is consumed. For example, during the decomposition of hydrogen peroxide, during the first half-life (from 0.00 hours to 6.00 hours), the concentration of H2O2 decreases from 1.000 M to 0.500 M. During the second half-life (from 6.00 hours to 12.00 hours), the concentration decreases from 0.500 M to...
39.5K
Long-term Depression01:05

Long-term Depression

33.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.4K
Characteristics of Life01:23

Characteristics of Life

263.5K
Biology is a natural science that studies life and living organisms, including their structure, function, development, interactions, evolution, distribution, and taxonomy. The field's scope is extensive and divided into several specialized disciplines, such as anatomy, physiology, ethology, genetics, and many more. All living things share a few key traits, including cellular organization, heritable genetic material and the ability to adapt/evolve, metabolism to regulate energy needs, the...
263.5K
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

41.3K
Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
41.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"Death Over Dessert" - A conversation with pharmacy students about what really matters in the end.

Currents in pharmacy teaching & learning·2022
Same author

Adding a Sixth Step: Emphasizing Pharmacists' Roles in Managing Polypharmacy.

Family medicine·2021
Same author

ABH Gel: Comforting Cure or Pricey Placebo?

Journal of the American Medical Directors Association·2020
Same author

Underestimation in Self-Assessment.

American journal of pharmaceutical education·2019
Same author

Safety and Efficacy of Lithium for Treating Bipolar Disorder In the Older Adult.

The Senior care pharmacist·2019
Same author

Drug Therapy for Gender Transitions and Health Screenings in Transgender Older Adults.

Journal of the American Geriatrics Society·2016

Related Experiment Video

Updated: Feb 14, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.7K

Atypical Antipsychotics in Late-Life and Treatment-Resistant Depression.

Trista Askins Bailey, Sehrish Panjwani

    The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
    |February 8, 2018
    PubMed
    Summary
    This summary is machine-generated.

    Older adults face higher risks of late-life depression and suicidal thoughts. This review examines atypical antipsychotics as a treatment option, considering their safety and effectiveness in this population.

    More Related Videos

    MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
    08:20

    MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

    Published on: August 11, 2015

    14.7K
    Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
    07:12

    Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

    Published on: August 2, 2021

    4.3K

    Related Experiment Videos

    Last Updated: Feb 14, 2026

    Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
    04:29

    Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

    Published on: January 7, 2019

    29.7K
    MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
    08:20

    MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

    Published on: August 11, 2015

    14.7K
    Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
    07:12

    Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

    Published on: August 2, 2021

    4.3K

    Area of Science:

    • Geriatric Psychiatry
    • Clinical Pharmacology

    Background:

    • Late-life depression presents significant risks, including suicidal ideation.
    • Older adults require tailored treatment strategies for depression.
    • Atypical antipsychotics are an established augmentation for depression in younger adults.

    Purpose of the Study:

    • To explore the use of atypical antipsychotics in older adults with depression.
    • To evaluate the safety and efficacy of atypical antipsychotics in this demographic.
    • To inform clinical practice regarding this treatment option.

    Main Methods:

    • Review of existing studies on atypical antipsychotics in geriatric populations.
    • Analysis of safety data, including black box warnings for dementia patients.
    • Assessment of efficacy in achieving symptom remission and preventing relapse.

    Main Results:

    • Atypical antipsychotics show potential as an augmentation strategy for late-life depression.
    • Safety concerns, particularly in older adults with dementia, necessitate cautious use.
    • Efficacy data suggests benefits but requires careful risk-benefit assessment.

    Conclusions:

    • Atypical antipsychotics may be a viable option for treating late-life depression.
    • Careful consideration of the black box warning and patient-specific factors is crucial.
    • Further research is needed to optimize the use of these agents in older adults.